Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

5.24USD
24 May 2019
Change (% chg)

$-0.02 (-0.38%)
Prev Close
$5.26
Open
$5.28
Day's High
$5.39
Day's Low
$5.18
Volume
136,064
Avg. Vol
313,262
52-wk High
$11.60
52-wk Low
$5.18

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.37
Market Cap(Mil.): $617.60
Shares Outstanding(Mil.): 117.86
Dividend: --
Yield (%): --

Financials

  AKBA.OQ Industry Sector
P/E (TTM): -- 93.20 35.48
EPS (TTM): -2.54 -- --
ROI: -39.33 7.47 11.75
ROE: -50.45 7.94 16.52

Earnings vs. Estimates